Tropical Weather Alert: For the latest updates on closures or modified hours for our UF Health clinical facilities, click here
About me
Dr. Kartik Cherabuddi provides clinical care to patients with complex infectious diseases; patients living with HIV; and internal medicine patients. He serves as a specialist for antibiotic resistant pathogen infections and is the Associate Epidemiologist and Director of Antimicrobial Stewardship Program at UFHealth.
A Master Clinician Society at UF inductee, Dr. Cherabuddi is a recognized Exemplary Clinician for multiple years for excellence in teaching through the Department of Medicine. He enjoys teaching medical students, residents and ID fellows. He has been recognized as the DOM Attending of the year by the residents.
Dr. Cherabuddi conducts research on antibiotic resistance, phage therapy and genetic sequencing of microorganisms. He collaborates with researchers at the UF Emerging Pathogen Institute on (re)emerging viral infections. He works with other investigators in Agriculture, Animal, Environmental sciences in a One Health approach to effectively use antibiotics and develop non-antibiotic interventions for controlling infections. He works in the arena of public health by educating providers in long term care facilities on infection control and stewardship.
Dr. Cherabuddi serves as Principal Investigator for multiple clinical trials assisting in the development of diagnostics and therapeutics for infectious diseases.
Dr. Cherabuddi participates in international infectious diseases committees to develop enhanced training in Antibiotic Stewardship. He advises and volunteers with education efforts around the world, including in Asia (India, Nepal) and Africa (Democratic Republic of Congo), in regards to infectious diseases control and management.
Active clinical trials
This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This…
- Investigator
- Kartik Cherabuddi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My research
Top areas of exploration
- Anti-Bacterial Agents , 10 publications
- COVID-19 , 5 publications
- Cefepime , 3 publications
- Vancomycin , 3 publications
Research activity
Accepted insurances
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesMy areas of focus
Stories and news
In the fight against long-haul COVID-19 symptoms, vaccination still best preventive option
September 28, 2021
The symptoms of COVID-19 can be terrible enough in the days and weeks after infection by the coronavirus. Many people, however, soon discover the microscopic…
College of Medicine, +2 more
UF Health researcher says vaccination key to protecting against the coronavirus delta variant
June 25, 2021
The coronavirus continues to mutate and evolve, and the latest in a parade of variants is causing particular worry among infectious disease specialists. The…
College of Medicine, +2 more